Skip to main content
QXL Diagnostics
Diabetes & Thyroid Verified Clinical Guide

C-Peptide Test in Bengaluru: Purpose, Preparation & Results

Assigned medical reviewer: Dr. Shantakumar MurudaMD (Biochemistry), Founder & CEO
October 20, 2026
5 min read
20 Sections
C-Peptide Test in Bengaluru: Purpose, Preparation & Results - QXL Diagnostics Bengaluru
Share Clinical Guide:
C-peptide is released when the pancreas makes insulin and can help assess the body’s own insulin production in selected clinical situations. It is not a routine diabetes screening test.

Quick answer: C-peptide is released when the pancreas makes insulin and can help assess the body’s own insulin production in selected clinical situations. It is not a routine diabetes screening test. Interpretation needs the glucose level, sampling conditions and kidney function. Blood testing commonly uses immunoassay; QXL must confirm its method, collection requirements and report time before an appointment in Bengaluru.

Also known as: C peptide, connecting peptide, endogenous insulin secretion

What is the C-Peptide test used for?#

  • Clarifying diabetes classification when the clinical picture remains ambiguous.
  • Specialist evaluation of documented hypoglycaemia with glucose, insulin and other indicated investigations.
  • Selected assessment of residual insulin secretion or follow-up after pancreatic intervention.

Conditions it helps investigate: Insulin secretion disorders

What does the test measure?#

  • C-peptide: Marker of endogenous insulin secretion, interpreted with concurrent glucose and clinical context.
  • Concurrent glucose, if ordered: Shows whether insulin secretion is appropriate for the prevailing glucose; confirm separate inclusion.

How is it tested?#

Antibody-based immunoassay commonly measures circulating C-peptide. The assay does not measure injected insulin itself. Platform calibration, cross-reactivity and sample requirements vary; QXL must confirm the actual assay and whether concurrent glucose is included.

Sample and preparation#

Specimen: Venous blood; serum or plasma suitability must be confirmed for the actual QXL assay.

  • The clinician must specify fasting, random or stimulated sampling; these are different protocols.
  • Arrange simultaneous glucose when requested and document the last meal and diabetes medicine timing.
  • Do not withhold insulin or deliberately induce a low glucose level at home; supervised hypoglycaemia testing requires a clinical setting.
Specimen detailWhat to confirm
VolumeConfirm minimum and paediatric volume with QXL test master.
ContainerUse the collection tube or container specified by the actual QXL test SOP.
StabilityConfirm separation deadline, validated transport temperature, cold-chain and stability window with QXL.
RejectionQXL must confirm identification, specimen quality, quantity and transport acceptance criteria.

How are the results interpreted?#

  • A result may indicate endogenous secretion only in relation to the glucose stimulus and clinical setting.
  • A lower result during hyperglycaemia may support insulin deficiency; it does not alone establish a diabetes subtype.
  • Kidney impairment can increase circulating C-peptide and complicate interpretation.

Reference interval: Use the method, units and context-specific interval or decision limits on the actual laboratory report; no universal numeric normal range is substituted.

What are the limitations?#

  • Recent food, current glucose, duration of diabetes and renal function influence the result.
  • Assays differ; results and cut-offs from separate platforms may not be directly interchangeable.
  • Insulin-secretagogue exposure can cause an endogenous secretion pattern; C-peptide alone cannot identify its cause.

How does it compare with other tests?#

  • C-peptide reflects endogenous secretion, whereas insulin assays may detect endogenous insulin and some injected analogues depending on the method.
  • Glucose and HbA1c remain established tools for diabetes diagnosis; C-peptide addresses a different question.

Notes for referring clinicians#

State the clinical question, relevant treatment and specimen timing. Discuss unexpected or discordant results with the laboratory before changing management.

Price, report time and home collection#

  • Price: Request the current QXL quote, included components and any collection charges.
  • Report time: Confirm test-specific QXL reporting time, its starting point, working-day conditions and any referral transit before collection.
  • Home collection: Ask QXL to confirm Bengaluru pincode eligibility, test suitability, collection timing and whether the visit is free.
  • Processing: QXL verification pending: performing laboratory, platform and in-house versus referral status.
  • Report review: Appropriately qualified laboratory authorisation is required. Ask QXL whether a separate report-discussion appointment is available. This content has not received medical sign-off.

Call +91 9964 639 639 or WhatsApp QXL to confirm the current quote, preparation and collection slot.

Frequently asked questions#

Does C-peptide measure the insulin I inject?#

No. Injected insulin does not contain C-peptide; the test assesses secretion from your own pancreas.

Can this diagnose diabetes by itself?#

No. Diabetes diagnosis uses validated glucose or HbA1c criteria in the appropriate clinical pathway.

Should I fast for C-peptide?#

Your clinician must specify a fasting, random or stimulated protocol. Do not substitute one protocol for another.

Why is glucose collected at the same time?#

C-peptide must be interpreted against the prevailing glucose to assess whether insulin secretion is appropriate.

Can kidney disease alter C-peptide?#

Yes. Reduced renal clearance can raise the level and limit interpretation.

Should I stop insulin before collection?#

Do not stop insulin yourself. Obtain a safe, individual medicine plan from your treating clinician.

Does a low value prove type 1 diabetes?#

No. Disease duration, glucose, kidney function and other clinical or antibody findings may be needed.

How do I confirm QXL collection and reporting?#

Ask QXL for the correct protocol, specimen instructions, concurrent glucose inclusion, current quote and reporting time.

Sources#

  • Tietz ninth edition, PDF pages 1734–1739: appropriate C-peptide use, endogenous secretion and assay variation.
  • A Manual of Laboratory and Diagnostic Tests ninth edition, PDF pages 364–365: C-peptide and concurrent glucose context. Current laboratory SOP must govern collection.

Educational information only; not a diagnosis or a substitute for a doctor’s advice.

Medical & Laboratory Disclaimer

Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.

Assigned Medical Reviewer

Dr. Shantakumar Muruda

MD (Biochemistry), Founder & CEO

QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

Share Clinical Guide:

Related Clinical Guides

Explore more evidence-based diagnostic articles and testing guidelines